Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.91 SEK 1.67% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vicore Pharma Holding AB
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Total Current Liabilities
kr39.9m
CAGR 3-Years
-10%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Current Liabilities
kr195.7m
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Current Liabilities
kr107.9m
CAGR 3-Years
28%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Current Liabilities
kr724m
CAGR 3-Years
43%
CAGR 5-Years
27%
CAGR 10-Years
20%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Current Liabilities
kr13.9B
CAGR 3-Years
21%
CAGR 5-Years
27%
CAGR 10-Years
34%
BioArctic AB
STO:BIOA B
Total Current Liabilities
kr125m
CAGR 3-Years
5%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.94 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's Total Current Liabilities?
Total Current Liabilities
39.9m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Total Current Liabilities amounts to 39.9m SEK.

What is Vicore Pharma Holding AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
27%

Over the last year, the Total Current Liabilities growth was 12%. The average annual Total Current Liabilities growth rates for Vicore Pharma Holding AB have been -10% over the past three years , 27% over the past five years .

Back to Top